Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Reboot antibiotics arsenal at any cost.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Mackenzie, Debora
- Source:
New Scientist. 5/24/2014, Vol. 222 Issue 2970, p10-11. 2p.
- Additional Information
- Subject Terms:
- Abstract:
The article discusses the World Health Organization's (WHO's) efforts to confront the problem of antibiotic drug resistance through changing pharmaceutical companies business models. Topic include the WHO's proposed 2014 action plan, comments from health law expert Kevin Outterson at Boston University in Massachusetts, and research and development (R&D) funding via the U.S. Biomedical Advanced Research and Development Authority (BARDA) and Europe's New Drugs for Bad Bugs (ND4BB) initiative.
No Comments.